Advances in the Treatment of Mucoepidermoid Carcinoma

Mucoepidermoid carcinoma (MEC) represents 10-15% of salivary neoplasms. Due to their low incidence, it is challenging to conduct clinical trials and develop treatment guidelines. Although surgery is the most common approach for a resectable tumor, various treatment options such as chemotherapy, radi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sama, Srikar, Komiya, Takefumi, Guddati, Achuta Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913015/
https://www.ncbi.nlm.nih.gov/pubmed/35317327
http://dx.doi.org/10.14740/wjon1412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913015/
https://www.ncbi.nlm.nih.gov/pubmed/35317327
http://dx.doi.org/10.14740/wjon1412

Ejemplares similares